Cerity Partners’s Amgen AMGN Stock Holding History

Cerity Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-300	Closed	-$106K	–	3410
2026 Q1	$106K	Buy	+300	New	+$107K	﹤0.01%	3020

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cerity Partners's AMGN Position: Q2 2026 in Review

Cerity Partners increased its Amgen (AMGN) stake by 2.6% in Q2 2026, buying an estimated $3.86M and bringing the position to 444,842 shares worth $161M. The position accounts for 0.19% of the portfolio, ranked #108.

Cerity Partners first reported a position in AMGN in Q4 2016 and has held it in 39 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Cerity Partners held 444,842 shares of Amgen worth $161M as of Q2 2026.
Cerity Partners bought 11,287 Amgen shares in Q2 2026, an estimated $3.86M.
Amgen made up 0.19% of Cerity Partners's portfolio in Q2 2026, its #108 holding.
Cerity Partners first reported a position in Amgen in Q4 2016 and has held it in 39 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.